1529454 RGD radiolabeled arginine-glycine-aspartic acid 42 1529411 RGD Rat Genome Database 32 1529613 RGD remitted geriatric depression 14 1529414 RGD radiolabeled Arg-Gly-Asp 13 1529449 RGD radiophotoluminescent glass dosimeter 10 1529487 RGD Reactive granulomatous dermatitis 9 1529432 RGD rare genetic disease 8 1529398 RGD RGD peptides 6 1529486 RGD Rayleigh-Gans-Debye 5 1529557 RGD recognize the tripeptide Arg-Gly-Asp 5 1529452 RGD random gap detection 4 1529514 RGD receptor-binding Arg-Gly-Asp 4 1529384 RGD 68Ga-NODAGA-RGD and 68Ga-TRAP 3 1529507 RGD receptor contains a highly conserved Arg-Gly-Asp 3 1529467 RGD cyclic-RGD dimer, designated as c 2 1529456 RGD radiofrequency glow discharge 2 1529408 RGD radiolabelled peptides based on the Arg-Gly-Asp 2 1529442 RGD rapid gas decompression 2 1529431 RGD ratios of cell-binding peptide 2 1529489 RGD recognizes adhesive proteins containing the Arg-Gly-Asp 2 1529548 RGD recombinant fibrillin-1 fragments containing the arginine-glycine-aspartic acid 2 1529547 RGD recombinant peptides containing the Arg-Gly-Asp 2 1529544 RGD red cells bearing arginine-glycine-aspartic acid 2 1529479 RGD Registrar-General's-Department 2 1529530 RGD regularized gradient descent 2 1529566 RGD residues and Arg-Gly-Asp 2 1529594 RGD reversed Arg-Gly-Asp 2 1529389 RGD RGD-containing peptide 2 1529477 RGD Rhodostomin, an Arg-Gly-Asp 2 1529659 RGD rich in arginyl-glycyl-aspartic acid 2 1529478 RGD Riemannian gradient descent 2 1529616 RGD rose bengal and arginylglycylaspartic acid 2 1529387 RGD 68Ga-NODAGA-RGD, and 4.1 0.7 for 68Ga-TRAP 1 1529386 RGD Ad5GFP-R7-arginine-glycine-aspartic acid 1 1529469 RGD age-related macular degeneration-targeting cyclic Arg-Gly-Asp 1 1529382 RGD Arg-Gly-Asp-d-Phe-Lys 1 1529474 RGD arginine-glycine-aspartate-rich acid 1 1529383 RGD Arginine-Glycine-Aspartic acid-D-Phenylalanine-Lysine 1 1529475 RGD arginine-rich peptide with a terminal arginine-glycine-aspartic acid 1 1529385 RGD AV-RSV-Lux could be effectively blocked by an arginine-glycine-asparagine 1 1529472 RGD beta8-integrin-regulated adhesion to Arg-Gly-Asp 1 1529473 RGD controlled-release carrier, the nanoprobes are functionalized with arginine-glycine-aspartate sequence 1 1529465 RGD cys-RGD peptide 1 1529466 RGD cysteine-rich epidermal growth factor-like repeats and the sequence Arg-Gly-Asp 1 1529461 RGD disulfide-rich proteins containing an Arg-Gly-Asp 1 1529380 RGD EGR-1-regulated cells and was reversed by treatment with Arg-Gly-Asp 1 1529381 RGD FL-RGD by covalently conjugating tumor marker cyclic arginine-glycine-aspartic acid tripeptide 1 1529462 RGD four cyclo(Arg-Gly-Asp-D-Phe-Lys) 1 1529403 RGD Fru-RGD-chol ligand, where a fructose and peptide Arg-Gly-Asp 1 1529459 RGD gastrin-releasing peptide, arginine-glycine-aspartate 1 1529401 RGD HS-PEG-RGD 1 1529460 RGD integrin-receptor-binding arginine-glycine-aspartic acid 1 1529464 RGD integrin-recognition domain Arg-Gly-Asp 1 1529402 RGD MAP-RGD, which is a recombinant MAP fused with an Arg-Gly-Asp 1 1529463 RGD pro-RNase delivery nanocolloids based on co-precipitation of pro-RNase and Arg-Gly-Asp 1 1529406 RGD R-Gel based on human type I collagen has multiple Arg-Gly-Asp 1 1529458 RGD radiochemistry development of PET tracers based on arginine-glycine-aspartic acid 1 1529457 RGD radiohalogenated Arg-Gly-Asp 1 1529410 RGD Radiolabeled peptides possessing an Arg-Gly-Asp 1 1529455 RGD radiolabeled tracer based on a cyclic Arg-Gly-Asp 1 1529409 RGD Radiopharmaceuticals containing the motive tripeptide arginyl-glycyl-asparatic acid 1 1529453 RGD radiopharmaceuticals currently under clinical investigation, such as integrin-binding arginine-glycine-aspartic acid 1 1529450 RGD radiosynthesis of clinical-grade (F)FPP 1 1529448 RGD radiotracers bound to arginine-glycine-aspartate 1 1529451 RGD radiotracers, Arg-Gly-Asp 1 1529413 RGD Raman molecules and then conjugating arginine-glycine-aspartic acid 1 1529443 RGD random gene dissection 1 1529446 RGD randomly generated data 1 1529447 RGD randomly oriented poly(vinyl alcohol) nano-fibrous scaffolds surface-modified with Arg-Gly-Asp 1 1529444 RGD range of decoupled and combined variations in integrin-binding peptide 1 1529445 RGD range of structures. alpha-Arginlyglycylaspartic acid 1 1529440 RGD range-gate depth 1 1529441 RGD ranging from nanometers to micrometers of the peptide arginine-glycine-aspartic acid 1 1529438 RGD rapid and chemoselective labeling of azide-modified glucose derivatives, Arg-Gly-Asp 1 1529439 RGD rapid and efficient chemical synthesis of a cyclic Arg-Gly-Asp 1 1529407 RGD RAS GTPase activating protein domain 1 1529412 RGD Rat calvarial osteoblasts attached to Arg-Gly-Asp 1 1529436 RGD rat cardiac cells were seeded in Arginine-Glycine-Aspartate 1 1529437 RGD rat cardiomyocytes were stimulated with a pentapeptide containing the Arg-Gly-Asp 1 1529433 RGD rat His-OPN was adequately phosphorylated and contained a functional arginine-glycine-aspartate 1 1529434 RGD rates by electrohydrodynamic atomization, and arginyl-glycyl-aspartic acid 1 1529435 RGD rating of gait disturbance 1 1529430 RGD ratio-of a solvated Arg-Gly-Asp 1 1529429 RGD ratios of peptides including the tripeptide arginine-glycine-aspartic acid 1 1529404 RGD RDG peptidic ligands c 1 1529425 RGD react to bond the cell-adhesive peptide arginine-glycine-aspartic acid 1 1529423 RGD react with mixtures of an adhesion-promoting peptide containing Arg-Gly-Asp 1 1529424 RGD reacted with thiol-containing peptide 1 1529427 RGD reaction of GRGDSPK 1 1529428 RGD reactions could be used to obtain arginylglycylaspartic acid 1 1529426 RGD reactive green dye 1 1529421 RGD reasoned that in hen egg white lysozyme the tripeptide L-arginyl-glycyl-aspartate 1 1529405 RGD REC Graphlet Degree 1 1529422 RGD recanalize blood vessels and systems based on chimeric Arg-Gly-Asp 1 1529420 RGD received TP-9201, an Arginine-Glycine-Aspartic acid 1 1529521 RGD recently been suggested that the Arg-Gly-Asp sequence 1 1529522 RGD recently developed a series of new Arg-Gly-Asp 1 1529519 RGD recently disclosed the discovery of a tripeptide Arg-Gly-Asp 1 1529485 RGD Recently, salmosin, a novel snake venom-derived disintegrin containing the Arg-Gly-Asp 1 1529524 RGD receptor antagonist, generated using the tripeptide Arg-Gly-Asp 1 1529525 RGD receptor binding based on its functional arginine-glycine-aspartic acid 1 1529523 RGD receptor binding domain of fibronectin 1 1529518 RGD receptor bound only to fibronectin of the various Arg-Gly-Asp 1 1529520 RGD receptor GP IIb/IIIa with adhesive fibrinogen sequence Arg-Pro-Asp 1 1529517 RGD receptor specific ligand molecules arginine-glycine-aspartic acid 1 1529512 RGD receptor specificity of novel peptide-dye conjugate arginine-glycine-aspartic acid 1 1529513 RGD receptor targeted cyclic peptide, Arg-Gly-Asp-DPhe-Lys 1 1529511 RGD receptor that has ligand binding specificity for the Arg-Gly-Asp 1 1529516 RGD receptor was conferred by incorporating an arginine-glycine-aspartic acid 1 1529515 RGD receptor-binding motif arginine-glycine aspartic acid 1 1529510 RGD receptor-binding peptides, a dicarba analogue of octreotide and the Arg-Gly-Asp 1 1529508 RGD receptor-guided design 1 1529509 RGD receptor-ligand binding of an arginine-glycine-aspartic acid 1 1529502 RGD receptors are established diagnostic targets, the cyclic Arg-Gly-Asp 1 1529503 RGD receptors bind ligands containing the Arg-Gly-Asp 1 1529501 RGD receptors expressed on inflammatory cells through its arginine-glycine-aspartate 1 1529506 RGD receptors following their interaction with surface-immobilized Arg-Gly-Asp 1 1529504 RGD receptors via a highly conserved arginine-glycine-aspartic acid 1 1529505 RGD receptors were blocked in normal platelets by the tripeptide Arg-Gly-Asp 1 1529500 RGD receptors, such as integrin, to adhesive motifs, such as Arg-Gly-Asp 1 1529498 RGD recognises peptide sequences containing arginine-glycine-aspartic acid 1 1529499 RGD recognition between a novel pillar(5)arene-based prodrug WP5-DOX and a Arg-Gly-Asp 1 1529495 RGD recognition between the integrin of RBCM and Arginine-Glycine-Aspartate 1 1529496 RGD recognition domains, Arg159-Gly-Asp161 1 1529494 RGD recognition of domains containing the arginine-glycine-aspartate 1 1529497 RGD recognition of short amino-acid sequences-arginine-glycine-aspartic acid 1 1529492 RGD recognition systems utilize the tripeptide Asp-Gly-Arg 1 1529493 RGD recognition was mediated via a second arginine-glycine-aspartic acid 1 1529488 RGD recognize and bind an arginine-glycine-aspartate 1 1529490 RGD recognize ligands with an Arg-Gly-Asp 1 1529491 RGD recognize the amino acid sequence Arg-Gly-Asp 1 1529560 RGD recognize the integrin-binding Arg-Gly-Asp 1 1529559 RGD recognize the linear sequence on the matrix ligands 1 1529556 RGD recognized by monoclonal antibodies that bind fibronectin near the arg-gly-asp 1 1529555 RGD recognizes and binds to Arg-Gly-Asp 1 1529558 RGD recognizes ECM proteins expressing an arginine-glycine-aspartic acid 1 1529553 RGD recognizing the conserved arg-gly-asp 1 1529552 RGD recombinant formulation of silk fibroin containing the arginine-glycine-aspartic acid 1 1529554 RGD recombinant GLA to nanoliposomes functionalized with Arginine-Glycine-Aspartic acid 1 1529550 RGD recombinant peptides lacking or including an arginine-glycine-aspartic acid 1 1529551 RGD recombinant polypeptide analogues containing the Arg-Gly-Asp 1 1529549 RGD recombinant protein, containing laforin's CBM fused to an Arg-Gly-Asp sequence 1 1529545 RGD recovery was significantly blocked with a cyclic arginine-glycine-aspartate 1 1529546 RGD recurrent GD 1 1529538 RGD red ginseng anti-hangover drink 1 1529539 RGD redirect binding, either toward alpha(V) integrin 1 1529536 RGD reduce plasma exposure, we constructed Arg-Gly-Asp 1 1529537 RGD reduce the non-specific renal uptake of Arg-Gly-Asp 1 1529542 RGD reduce the renal uptake of Arg-Gly-Asp 1 1529543 RGD reduced density gradient 1 1529540 RGD reduced gradient density 1 1529541 RGD reduced immunogenicity, two staphylokinase variants containing Arg-Gly-Asp 1 1529480 RGD Reducing side reactions in protease-catalyzed tripeptide 1 1529534 RGD reduction, denuded arterioles were treated with fibronectin antiserum or Arg-Gly-Asp 1 1529535 RGD referral to a genetics department 1 1529533 RGD refractory GD 1 1529528 RGD regard to BM components, inducible dentinogenesis was Arg-Gly-Asp 1 1529529 RGD regeneration by introducing Arg-Gly-Asp 1 1529526 RGD regeneration matrices covalently modified with an Arg-Gly-Asp 1 1529527 RGD region including Arg-Gly-Asp 1 1529531 RGD region requires two critical amino acid sequences--an Arg-Gly-Asp 1 1529532 RGD regions include calcium-binding structures and an arg-gly-asp 1 1529619 RGD regulatory effects of Fbln7-C on arginine-glycine-aspartic acid 1 1529617 RGD related constructs containing the Arg-Gly-Asp 1 1529618 RGD related to Arg-Gly-Asp 1 1529622 RGD related to the arginine-glycine-aspartate 1 1529623 RGD relative exposure of the cell adhesive arginine-glycine-aspartic acid 1 1529620 RGD relative glandular dose 1 1529621 RGD release systems established by an arginine-glycine-aspartic acid 1 1529615 RGD release was suppressed by peptides containing the sequence arginine-glycine-aspartic acid 1 1529609 RGD relevant peptide, a peptide containing the cell binding domain Arg-Gly-Asp 1 1529610 RGD relevant peptidomimetic bearing an Arg-Gly-Asp 1 1529608 RGD relies on electrically-induced conformational changes within surface-grafted arginine-glycine-aspartate 1 1529614 RGD remodeling peptides and Arginine-glycine-lycinee 1 1529611 RGD renal glomerular disease 1 1529612 RGD render dispensable a highly conserved Arg-Gly-Asp 1 1529607 RGD renoprotective effect of arginine-glycine-aspartic acid 1 1529602 RGD repeat domains, two N-linked glycosylation sites, an integrin association motif 1 1529603 RGD repeated fibronectin-derived sequence, TGRGDSPAS, and arginylglycylaspartic acid 1 1529600 RGD repeated gastric distension 1 1529601 RGD repeated structures of the cell adhesive Arg-Gly-Asp 1 1529606 RGD repeats, a linker segment containing a cell-adhesive Arg-Gly-Asp 1 1529604 RGD repetitive, extremely acidic protein segment that includes the Arg-Gly-Asp 1 1529605 RGD replaced by a provisional matrix composed of arginine-glycine-aspartate 1 1529599 RGD replicative adenovirus, Ad5-delta24-arginine-glycine-aspartate 1 1529597 RGD report a novel Arg-Gly-Asp peptide 1 1529598 RGD report a three-dimensional graphene/arginine-glycine-aspartic acid 1 1529591 RGD report on additional Arginin-Glycin-Aspartat 1 1529592 RGD report that an antibody engineered to express three Arg-Gly-Asp 1 1529589 RGD report that integrin-dependent cell adhesion to the Arg-Gly-Asp 1 1529590 RGD report the construction and characterization of arginine-glycine-aspartic acid 1 1529595 RGD report the effects of the arginine-glycine-aspartic acid 1 1529596 RGD report the facile synthesis of arginine-glycine-aspartic acid 1 1529593 RGD report the synthesis of cyclic arginine-glycine-aspartic acid 1 1529588 RGD reported for the binding between integrins and Arg-Gly-Asp 1 1529586 RGD reported the potential use of Arg-Gly-Asp 1 1529587 RGD reports that IVIg contains antibodies to the Arg-Gly-Asp 1 1529582 RGD representative cell adhesion motif, Arg-Gly-Asp 1 1529583 RGD required a selective interaction of virus arginine-glycine-aspartic acid 1 1529580 RGD required an Arg-Gly-Asp 1 1529581 RGD required for this integrin's binding to fibrinogen is the Arg-Gly-Asp 1 1529585 RGD requires fibronectin and involves arginine-glycine-aspartate 1 1529584 RGD requires specific ligands based on Arg-Gly-Asp 1 1529578 RGD research, cyclised peptides containing Arg-Gly-Asp 1 1529579 RGD residue is essential for integrin binding to the Arg-Gly-Asp 1 1529577 RGD residues 140-164 of integrin beta1 comprise an Arg-Gly-Asp 1 1529573 RGD residues containing the arginyl-glycyl-aspartic acid 1 1529574 RGD residues contains the tripeptide sequence Arg-Gly-Asp 1 1529571 RGD residues flanking the Arg-Gly-Asp 1 1529572 RGD residues in length and a Pro/Glu(P/E)-Pro/His(P/H)-Lys-Gly-Asp 1 1529575 RGD residues in length, contains the Arg-Gly-Asp 1 1529576 RGD residues of the Arg-Gly-Asp 1 1529569 RGD residues, as well as the sequence Arg-Gly-Asp 1 1529570 RGD residues; (b) an Arg-Gly-Asp 1 1529567 RGD respective immobilized ligands by a hexa-peptide containing the sequence Arg-Gly-Asp 1 1529568 RGD respectively, through binding to an Arg-Gly-Asp 1 1529563 RGD respond to adhesive ligands such as arginine-glycine-aspartate 1 1529564 RGD respond to the addition of fibronectin or arginine-glycine-aspartate 1 1529561 RGD response to treatment with GST/III1H,8-10 (4.050.93-fold), GST/III1H,8,10 (2.910.49-fold), or GST/III1H,8 1 1529562 RGD responses could be abrogated by ARg-Gly-Asp 1 1529565 RGD responses through the integrin-binding Arg-Gly-Asp 1 1529647 RGD responsive interface for the display of the integrin-specific ligand, Arg-Gly-Asp 1 1529648 RGD responsive site, and arginine-glycine-aspartic acid 1 1529651 RGD responsive to peptides and peptidomimetics containing an arginine-glycine-aspartic acid 1 1529652 RGD restored by pretreatment with Arg-Gly-Asp 1 1529649 RGD resultant dendrimer-modified gold nanorods conjugated with arginine-glycine-aspartic acid 1 1529650 RGD resulted in multimeric ligands superior to c 1 1529645 RGD resulting amino-acid sequence has an Arg-Gly-Asp 1 1529646 RGD resulting tetrameric conjugate DOTPI 1 1529483 RGD Results demonstrate that in the presence of an arginine-glycine-aspartic acid 1 1529484 RGD Results indicated that GST-RHO 1 1529643 RGD results show that the surface tethered with Arg-Gly-Asp 1 1529644 RGD results showed that the Arg-Gly-Asp 1 1529481 RGD Results with an Arginine-glycine aspartic acid 1 1529482 RGD Results: A novel nanovehicle composed of arginine-glycine-aspartate 1 1529399 RGD RESULTS: By using site-directed mutagenesis, an Arg-Gly-Asp 1 1529638 RGD retro- and retro-inverso peptides of the Arg-Gly Asp 1 1529636 RGD retrograde 1 1529637 RGD retromalleolar groove depth 1 1529641 RGD reveal preferential binding of ChAdOx1's penton arginine-glycine-aspartic acid 1 1529642 RGD reveal tripeptide Arginine-Glycine-Aspartate 1 1529639 RGD reveal tubular and vascular Arg-Gly-Asp 1 1529640 RGD revealed that a 36-amino acid Arg-Gly-Asp 1 1529634 RGD revealed that gelatin contains arginyl-glycyl-aspartic acid 1 1529635 RGD revealed that salmon IGFBP-1 does not have an Arg-Gly-Asp 1 1529633 RGD revealed that the basic domain of Tat, not the arg-gly-asp 1 1529627 RGD revealed the presence of a conserved arginine-glycine-aspartic acid 1 1529628 RGD revealed the presence of an Arg-Gly-Asp 1 1529626 RGD reveals the surface location of an integrin-binding Arg-Gly-Asp 1 1529631 RGD reversed by inclusion in soft agar of the Arg-Gly-Asp 1 1529632 RGD reversed with the potent small molecule, arginine-glycine-aspartic acid tripeptide 1 1529629 RGD reversible uncaging of bioactive ligands, such as Arg-Gly-Asp 1 1529630 RGD reversibly bind to the arginine-glycine-aspartic acid 1 1529624 RGD reverted by further modification with arginylglycylaspartic acid 1 1529625 RGD reverted to the standard Arg-Gly-Asp 1 1529657 RGD review committee on animal care.USPIOs were coated with integrin-specific 1 1529658 RGD review common peptides displayed on phages, including arginine-glycine-aspartic acid 1 1529660 RGD review focuses on an arginine-glycine-aspartic acid 1 1529661 RGD review introduces our approaches that employ an Arg-Gly-Asp 1 1529400 RGD RGD control hydrogel 1 1529392 RGD RGD peptide with AdZ.F 1 1529393 RGD RGD peptides: preclinical evaluation of Ga-TRAP 1 1529390 RGD RGD, and study the transformable features induced by ligand 1 1529395 RGD RGD-based engineered scaffolds, where the tri-peptide, Arg-Gly-Asp 1 1529388 RGD RGD-c 1 1529415 RGD RGD-containing peptide GCRGYGRGDSPG 1 1529391 RGD RGD-EVs 1 1529396 RGD RGD-Glu-6Ahx-RM2 1 1529416 RGD RGD-motifs. v 1 1529397 RGD RGD-PCP copolymers were fabricated by grafting Arg-Gly-Asp 1 1529394 RGD RGD-TMV hosted bioadhesive peptide 1 1529419 RGD RGDfK 1 1529655 RGD rigid 1 1529656 RGD ring gradient descriptor 1 1529653 RGD ring-opening metathesis polymerization methods with polyethylene-containing macromonomer and arginylglycylaspartic acid 1 1529654 RGD rings is inhibited by the Arg-Gly-Asp 1 1529667 RGD robust biological effects and Arg-Gly-Asp 1 1529666 RGD rolapitant + granisetron + dexamethasone 1 1529476 RGD Role of tripeptide Arg-Gly-Asp 1 1529670 RGD roles in host cell interactions, including an Arg-Gly-Asp 1 1529669 RGD roles of the integrin alpha5beta1-mediated signal through the Arg-Gly-Asp 1 1529668 RGD root groove depth 1 1529665 RGD root mean square fluctuation increase of the fibronectin arginylglycylaspartic acid 1 1529664 RGD routine gastric decompression 1 1529470 RGD Ruminant Genome Database 1 1529471 RGD Russian HPeV-5 strain, the lack of the arginine-glycine-aspartic acid 1 1529663 RGD ruthenium(II) polypyridyl-Arg-Gly-Asp 1 1529417 RGD RXDLXXL-coupled cyclic arginine-glycine-aspartate 1 1529418 RGD RYRGDLGRR, containing a putative integrin-binding 1 1529468 RGD SCM-chitin-RGDS based on Arg-Gly-Asp 1 1529662 RGD three-residue sequence Arg-Gly-Asp 1